COR AmerisourceBergen Corporation Earnings per share for the last twelve months

COR (Cencora Inc) - company brandmark

The annual net income per share trend demonstrates the resilience of Cencora, Inc. (COR), which leverages oligopolistic influence in distribution and inelastic demand. Despite logistical risks and geopolitical barriers, the company is optimizing its supply chains. Growth in the GLP-1 and oncology segments serves as a powerful catalyst, while 18.08 is recorded as the baseline value for the issuer's current yield.

COR (Cencora, Inc.) Net earnings per share for the last 12 months history from 02/21/2024 to 11/14/2026

Analytical breakdowns for AmerisourceBergen (COR)

- stock price and consensus target price:
Stock Price AmerisourceBergen Corporation|COR - Average Forecast Price
- market capitalization data:
Market Value Cencora|COR - Business Value
- shareholders' equity book value data:
Book Value per Share Cencora|COR - Company Net Assets|Market Value to Book Value Ratio cencora.com|COR - Company Assets
- debt burden and liquidity indicators:
Debt to Equity Cencora, Inc.|COR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital AmerisourceBergen Corporation|COR - Company Aggregate Debts|Debt to Book Value AmerisourceBergen Corporation|COR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Cencora|Quick Liquidity cencora.com
- net income and valuation multiples indicators:
COR - Company Profit|Projected Future Earnings Cencora, Inc.|COR - Price to Earnings Ratio|Projected Price to Earnings AmerisourceBergen Corporation|COR - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple AmerisourceBergen Corporation|COR - Operating profit before deduction of amortization|Earnings per share for the last twelve months Cencora|COR - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cencora.com|COR - Earnings per share increase in current year|Net earnings per share growth forecast for next year Cencora, Inc.
- revenue and sales details:
COR - Company Annual Revenue|Projected Sales Volume Cencora|COR - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Cencora Inc
Analysis of all company metrics:Cencora - COR
Mass-produced product of Cencora Inc

Cencora, Inc. stable commission flows from pharmaceutical distribution form the foundation for growth in earnings per share. By analyzing changes in the rolling net income per share, an investor assesses the business's actual specific annual yield, which allows them to filter out reporting volatility and determine the fair value of capital, avoiding overpayment during peaks of market optimism.

Competing companies

CVS: Net earnings per share for the last 12 months|McKesson Corp (MCK) - Net earnings per share for the last 12 months|Cardinal Health Corp (CAH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Henry Schein Dental (HSIC)|Earnings per share for the last twelve months prestigebrands.com|Earnings per share for the last twelve months WGRX|Net earnings per share for the last 12 months YI (111, Inc)|China Jo-Jo Drugstores - Earnings per share for the last 12 months|Earnings per share for the last twelve months Universe Pharmacy UPC|biodexapharma.com (BDRX) - Net earnings per one share for the last twelve months|HKPD - Earnings per share for the last twelve months|Earnings per share for the trailing year BIMI (usbimi.com)|jiuzhou-drugstore.com (CJJD) - Earnings per share for the last twelve months|Earnings per share for the last 12 months WBA